The article calls for action to address prostate cancer health disparities.
Spencer Heaton, MD, MBA, Chief Medical and Commercial Officer at Lynx Dx, was featured along with Walter Rayford, PhD, MD, MBA, President of the Consortium on Disparities of Urologic Conditions (ConDUC), in an article by Chief Healthcare Executive. The experts emphasize the importance of early detection in narrowing the prostate cancer health disparity gap, particularly highlighting the racial differences in prevalence, outcomes, and mortality rates, and call for a sustained commitment from stakeholders to address systemic issues contributing to these disparities.
Click here to read the full article.
About Lynx Dx
Using technology developed at the University of Michigan, Lynx Dx provides best-in-class diagnostic testing services to help people live healthy and productive lives. The company’s mission is to develop superior genomic tests where there is clear patient need. Lynx Dx produces tests with the highest degree of accuracy, efficiency combined with an unparalleled customer experience.